Cardiology Today | Secondary prevention of CVD with colchicine is a major focus for the cardiology community, especially after recent presentations of the COLCOT and COLCHICINE-PCI trials at the American Heart Association Scientific Sessions in November.Repurposing of drugs for CV applications has become more common, as researchers have learned how the mechanisms of certain drugs may offer…
The Society for Cardiovascular Angiography and Interventions has released a consensus statement on how catheterization laboratories should manage the technical aspects of PCI for patients…
This month’s Healio Exclusive highlights the efficacy of Janus kinase inhibitors in the management of ulcerative colitis and Crohn’s disease.For UC, we have here in…
Despite an existing class-wide black box warning, 45% of health care providers felt cardiovascular concerns related to Janus kinase inhibitors “were irrelevant” to patients with…
Datopotamab deruxtecan failed to extend OS vs. chemotherapy for adults with advanced breast cancer, according to the agent’s manufacturer.Datopotamab deruxtecan (AstraZeneca/Daiichi Sankyo) is a TROP2-directed…
Children and adolescents diagnosed with COVID-19 were more likely to develop new-onset type 2 diabetes than those who had other respiratory infections, according to data…
The FDA has approved the Stelara biosimilar, Imuldosa, for Crohn’s disease, ulcerative colitis and all other indications approved for the reference product, the latest addition…
CARLSBAD, Calif. — Retinal detachment repair in pediatric patients yielded favorable anatomic and visual outcomes compared with no intervention, according to a poster presented at…
Beer and ciders outranked spirits, red wine and other types of alcohol in elevating the risk for gout among men and women, according to a…
The first over-the-counter monograph order request tier 1 application for bemotrizinol, an active sunscreen ingredient, has been submitted to the FDA, dsm-firmenich announced in a…
BOSTON — Among patients with interstitial lung disease, 30% had pulmonary arterial hypertension and 20% had right ventricular hypertrophy, according to data presented at the…
